|
ZNF625 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.463000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.163600E-01 |
| Normal-vs-Stage2 |
8.359600E-01 |
| Normal-vs-Stage3 |
8.636300E-02 |
| Normal-vs-Stage4 |
2.576900E-03 |
| Stage1-vs-Stage2 |
7.938600E-01 |
| Stage1-vs-Stage3 |
2.285200E-01 |
| Stage1-vs-Stage4 |
7.836700E-03 |
| Stage2-vs-Stage3 |
2.744800E-01 |
| Stage2-vs-Stage4 |
3.245600E-02 |
| Stage3-vs-Stage4 |
3.034800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.497400E-01 |
| Normal-vs-AfricanAmerican |
6.339800E-01 |
| Normal-vs-Asian |
8.264200E-03 |
| Caucasian-vs-AfricanAmerican |
6.252400E-01 |
| Caucasian-vs-Asian |
8.422000E-03 |
| AfricanAmerican-vs-Asian |
4.277700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.162300E-02 |
| Normal-vs-Female |
7.777600E-01 |
| Male-vs-Female |
7.929500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.494200E-01 |
| Normal-vs-Extreme_Weight |
8.663700E-02 |
| Normal-vs-Obese |
6.222000E-01 |
| Normal-vs-Extreme_Obese |
1.861220E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.152200E-01 |
| Normal_Weight-vs-Obese |
4.824400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.087600E-01 |
| Extreme_Weight-vs-Obese |
2.339400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.779200E-01 |
| Obese-vs-Extreme_Obese |
4.217600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.238750E-01 |
| Normal-vs-Age(41-60Yrs) |
6.595000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.516300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.723900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.950400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.489200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.935440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.819900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.494200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.072200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.930000E-01 |
| Normal-VS-Type2 PRCC |
2.768400E-04 |
| Normal-VS-KIRP CIMP |
1.442160E-02 |
| Normal-VS-Unclassified PRCC |
9.135000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.22650000000668E-06 |
| Type1 PRCC-VS-KIRP CIMP |
6.064200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.894000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.859000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.078250E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.541700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.422180E-03 |
| Normal-vs-N1 |
5.466100E-02 |
| Normal-vs-N2 |
2.48650000034267E-07 |
| N0-vs-N1 |
8.428200E-01 |
| N0-vs-N2 |
2.805800E-02 |
| N1-vs-N2 |
2.477600E-03 |
|
|
